Right now we don’t have any job openings, volunteer opportunities, or upcoming events.
Log in or sign up to be among the first to know when new openings or events are added!
The Global Health Innovative Technology Fund
(GHIT Fund) is an international public-private partnership fund between five
Japanese pharmaceutical companies, two government ministries and the Bill &
Melinda Gates Foundation. Launched in April 2013 with a five-year commitment of
more than US$100 million, the organization taps Japanese research and
development (R&D) innovation to fight neglected diseases. It is the first
fund to involve a consortium of pharmaceutical companies, government and civil
society working together to support R&D for neglected diseases. The combination
of Japan’s government and its pharmaceutical industry—the third largest in the
world—brings a powerful engine of knowledge and innovation to the development
of medications for the developing world. The GHIT Fund invests via grants in
the development of new drugs, vaccines, or diagnostics for infectious diseases
that are prevalent in the developing world, including HIV/AIDS, Tuberculosis,
Malaria, and other NTDs.